GET THE APP

Study of cord blood ischemia modifi ed albumin levels in the evaluation of birth asphyxia

Abstract

Soumyadeep Biswas, Pinaki Sarkar, Indranil Chakraborty, Sibarjun Ghosh, Ramesh Chandra Halder

Objective: In the birth asphyxia several new biochemical markers are now investigated. Recent studies indicate the role of ischemia modified albumin (IMA), a biomarker determined by assay of cobalt binding activity of albumin. The aim of this study was to evaluate the role of IMA in birth asphyxia. Materials and Methods: Forty newborns with Apgar score <7 were selected at random. Low-birth weight, premature and newborns from caesarian section were excluded. IMA was determined by assay of its cobalt binding activity with spectrophotometer. Mothers with a history of preeclampsia and pre-existing renal disease were kept out of the study. Similar observations were made in 40 normal newborns taken as control. Results: Cord blood IMA levels were higher in asphyxiated newborns compared to controls (55.7 ± 1.7 U/ml compared with 32.44 ± 1.15 U/ml). Raised levels of IMA in those subjects had shown very significant correlations with the Apgar score of 5 min, a finding also observed in the case of controls. Conclusion: The findings of the current study indicate that IMA can be a very useful marker in the evaluation of birth asphyxia.

PDF